Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells

Breast Cancer Research and Treatment

Volumn 62, Issue 3, 2000, Pages 167-175

  Jeng, Meei Huey ^a   Yue, Wei ^a   Eischeid, Anne ^a   Wang, Ji Ping ^a   Santen, Richard ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cell proliferation; Estrogen deprivation; Estrogen receptor; MAP kinase; Transcriptional regulation

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA (3,4 DIMETHOXYBENZYLIDENE) 2 PYRIDYLACETONITRILE; COMPACTIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; GENISTEIN; MITOGEN ACTIVATED PROTEIN KINASE; THYMIDINE; TRITIUM;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; GENETIC TRANSFECTION; HORMONE INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL DIVISION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; FEMALE; FLAVONOIDS; HUMANS; MAP KINASE SIGNALING SYSTEM; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, ESTROGEN; THYMIDINE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0033765376     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006406030612     Document Type: Article

References (39)

1. Endocrine treatment of breast cancer in women
2. Use of aromatase inhibitors in breast carcinoma
3. Estrogen derpivation causes estradiol hypersensitivity in human breast cancer cells
4. Antiestrogens: Future propspects
5. Alternations in transforming growth factor- α and-β production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth
6. Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells
7. Proliferation, hormone responsiveness and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens
8. Cellular and molecular events in loss of estrogen sensitivity in ZR-75-1 and T-47-D human breast cancer cells
9. Adaption of oestrogen-dependent MCF-7 cells to low oestrogen (phenol red-free) culture
10. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells
11. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo
12. Diversity in function and regulation of MAP kinase pathways
13. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf
14. Transcriptional regulation by MAP kinases
15. The mitogen-activated protein kinase signal transduction pathway
16. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
17. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
18. Myc and Ras collaborate in inducing accumulation of active cyclin E/cdk 2 and E2F
19. Mechanism of estrogen activation of c-myc oncogene expression
20. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol
21. Coupling of dual signaling pathways: Epidermal growth factor action involves the estrogen receptor
22. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
23. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
24. The MAPK signaling cascade
25. Convergence of progesterone with growth factor and cytokine signaling in breast cancer. Progesterone receptors regulate signal transducers and activators of transcription expression and activity
26. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways
27. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity
28. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor
29. Specific labelling of isoprenylated proteins: Application to study inhibitors of the post-translational farnesylation and geranylgeranylation
30. Paclitaxel (taxol) inhibitors protein isoprenylation and induces apoptosis in PC-3 human prostate cancer cells
31. Selective inhibition of Ras-dependent cell growth by farnesylthiosalisylic acid
32. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo
33. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
34. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation
35. Parallel signal processing among mammalian MAPKs
36. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
37. 17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and 2-MAP kinases activation
38. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase
39. MCF-7: The first hormoneresponsive breast cancer cell line